Wed. 8 May 2024, 6:39pm ET
Benzinga
Earnings, Earnings Beats, News
DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.16) by 12.5 percent. This is a 30 percent increase over losses of $(0.20) per share from the same period last year.